Detalles de la búsqueda
1.
Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations.
Eur J Haematol
; 100(5): 395-402, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360184
2.
Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.
Biol Blood Marrow Transplant
; 22(6): 1037-1042, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26970381
3.
A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure.
Hemasphere
; 4(3): e401, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32647803
4.
High prevalence of CD3, NK, and NKT cells in the graft predicts adverse outcome after matched-related and unrelated transplantations with post transplantation cyclophosphamide.
Bone Marrow Transplant
; 55(3): 544-552, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31541204
Resultados
1 -
4
de 4
1
Próxima >
>>